These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7887648)

  • 1. [Dynamic change of serum UFT concentration in a patient with tongue cancer complicating chronic renal failure].
    Yanagisawa T; Arimoto T; Kishimoto H; Takahashi Y; Urade M; Yoshioka W
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):553-6. PubMed ID: 7887648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetic study of UFT in cancer patients receiving maintenance dialysis].
    Sakamoto K; Arita S; Hisikawa E; Yaguchi H; Arima H; Matsumoto M; Hachisu T; Kashiwabara H; Yokoyama T
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):239-44. PubMed ID: 7857099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [5-FU, FT-207 and uracil concentrations in the serum and tissues of patients with cervical cancer after UFT oral administration].
    Tanimura T; Kaneshige E; Fujiwara K; Kobashi Y; Inoue K; Kono I; Sekiba K
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):349-55. PubMed ID: 3080967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [5-FU concentration in blood and tissue of patients with renal cell carcinoma after administration of UFT].
    Masuda F; Suzuki M; Ohnishi T; Nakada J; Mori Y; Iizuka N; Machida T
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):320-4. PubMed ID: 3918507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study of urinary tegafur, 5-fluorouracil (5-FU) and uracil concentrations in the cases of gastric carcinoma for the confirmation of drug-taking compliance after UFT oral administration].
    Ohsawa S; Kondo Y; Shiroto H; Masuko H; Fukushima T; Kataoka A; Ohmori K; Sawaguchi Y; Baba E; Takahashi T
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2189-93. PubMed ID: 1444485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Portal-transfer of an orally administered anti-cancer agent analysis of the time course of portal blood and systemic blood levels of preoperatively administered UFT].
    Yoshikawa K; Hashimoto T; Yamaguchi T; Dousei T; Moriguchi S; Taniguchi M; Ueda H; Taketani S; Utsumi T; Suhara H
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):501-5. PubMed ID: 8129391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [5-FU concentration in blood and tissue of patients with primary lung cancer after oral administration of UFT].
    Oiwa T; Saito H
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):525-30. PubMed ID: 3082289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the concentrations of 5-fluorouracil (5-FU), tegafur (ET) and uracil in bile: comparison of UFT or FT].
    Tomita T; Tajima T; Ishibashi M; Tagaya N; Aoki H; Itoh S; Kadowaki A; Kogure H; Tajima Y
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3755-62. PubMed ID: 2512859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The serum and tissue concentrations of tegafur, 5-fluorouracil and uracil in patients with gastric and colorectal cancers after oral administration of UFT].
    Takahashi N; Nitta A; Saitou T; Mori Y; Kunii Y; Kikuchi K
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2319-23. PubMed ID: 3136701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood concentrations of futraful, uracil and 5-fluorouracil (5-FU) after UFT administration in the various reconstructions after gastrectomy. Saitama UFT Research Group].
    Suda Y; Uchida K; Okamura H; Oshima Y; Shimizu M; Miyakawa T; Okubo S; Shiina E; Hosoda Y; Tokura Y
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2181-7. PubMed ID: 1444484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of long-term administration of oral anti-cancer agent].
    Watanabe H; Sakakibara N
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):637-42. PubMed ID: 8470922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Level of 5-FU in cancerous and normal tissues of nude mice after oral administration of tegafur coadministered with uracil (UFT)].
    Sekiguchi I; Suzuki M; Tamada T; Nishida M
    Gan To Kagaku Ryoho; 1985 May; 12(5):1094-8. PubMed ID: 3922312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of combination chemotherapy with topical application of 5-FU ointment to mice's tongue and UFT].
    Tateishi A; Sakaki Y; Kameyama Y; Hara I; Yamada N
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1877-85. PubMed ID: 2118335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [FT, 5-FU and uracil concentrations of the blood, bile and tissue of hepatoma with liver cirrhosis after oral administration of UFT].
    Oguma S; Sakai K; Sato R; Ouchi K; Owada Y; Sato T
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1122-8. PubMed ID: 3032114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of gastrectomy on serum 5-FU concentrations of patients administered UFT per os].
    Yamamoto Y; Amano T; Fujimoto Y; Imada T; Tamura S; Noguchi Y; Matsumoto A
    Gan No Rinsho; 1987 Apr; 33(4):377-81. PubMed ID: 3106673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
    Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [UFT concentration in serum and tissues of patients with gynecologic malignant tumors following oral administration].
    Inoue S; Shibata S; Okumura A; Tanaka T; Onitsuka Y; Yoshimura T; Aiko A; Ikuta Y; Fukuma K; Matsuura K
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):499-504. PubMed ID: 3923940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Level of 5-FU in uterine cervical cancer tissue after oral administration of UFT].
    Suzuki M; Sekiguchi I; Ohwada M; Tamada T
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2139-44. PubMed ID: 3933435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
    Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [5-Fluorouracil, tegafur, and uracil concentrations in serum and tissue of the patients with hepatocellular carcinoma after UFT administration].
    Suenaga M
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3313-8. PubMed ID: 2825604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.